Your browser doesn't support javascript.
loading
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Pym, Alexander S; Diacon, Andreas H; Tang, Shen-Jie; Conradie, Francesca; Danilovits, Manfred; Chuchottaworn, Charoen; Vasilyeva, Irina; Andries, Koen; Bakare, Nyasha; De Marez, Tine; Haxaire-Theeuwes, Myriam; Lounis, Nacer; Meyvisch, Paul; Van Baelen, Ben; van Heeswijk, Rolf P G; Dannemann, Brian.
Afiliación
  • Pym AS; Medical Research Council and Kwazulu Research Institute for TB and HIV (K-RITH), Durban, South Africa Alex.Pym@k-rith.org.
  • Diacon AH; Division of Medical Physiology and Dept of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for Tuberculosis Research, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, Sout
  • Tang SJ; Tuberculosis Dept, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Research Institute, Beijing, China.
  • Conradie F; Clinical HIV Research Unit, Dept of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Danilovits M; Tartu University Lung Hospital, Tartu, Estonia.
  • Chuchottaworn C; Chest Disease Institute, Ministry of Public Health, Nonthaburi, Thailand.
  • Vasilyeva I; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russia.
  • Andries K; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • Bakare N; Janssen Research & Development LLC, Titusville, NJ, USA.
  • De Marez T; Janssen Research & Development LLC, Titusville, NJ, USA.
  • Haxaire-Theeuwes M; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • Lounis N; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • Meyvisch P; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • Van Baelen B; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • van Heeswijk RP; Janssen Infectious Diseases BVBA, Beerse, Belgium.
  • Dannemann B; Janssen Research & Development LLC, Titusville, NJ, USA.
Eur Respir J ; 47(2): 564-74, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26647431
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Extensivamente Resistente a Drogas / Diarilquinolinas / Antituberculosos Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Año: 2016 Tipo del documento: Article País de afiliación: Sudáfrica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Extensivamente Resistente a Drogas / Diarilquinolinas / Antituberculosos Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Año: 2016 Tipo del documento: Article País de afiliación: Sudáfrica